References
- Weir EG, Li Ansari-Lari M, Batista DA, Griggin CA, Fuller S, Smith BD, et al. Acute bilineal leukemia: a rare disease with poor outcome. Leukemia. 2007;21:2264–70.
- Rubnitz JE, Onciu M, Pounds S, Shurtleff S, Cao X, Raimondi SC, et al. Acute mixed lineage leukemia in children: the experience of St Jude Children's Research Hospital. Blood. 2009;113:5083–9.
- Rubio MT, Dhedin N, Boucheix C, Bourhis JH, Reman O, Boiron JM, et al. Adult T-biphenotypic acute leukaemia: clinical and biological features and outcome. Br J Haematol. 2003;123:842–9.
- Legrand O, Perrot JY, Simonin G, Baudard M, Cadiou M, Blanc C, et al. Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression. Br J Haematol. 1998;100:147–55.
- Killick S, Matutes E, Powles RL, Hamblin M, Swansbury J, Treleaven JG, et al. Outcome of biphenotypic acute leukemia. Haematologica. 1999;84:699–706.
- Aribi A, Bueso-Ramos C, Estey E, Estrov Z, O'Brien S, Giles F, et al. Biphenotypic acute leukaemia: a case series. Br J Haematol. 2007;138:213–6.
- Matutes E, Pickl WF, van't Veer M, Morilla R, Swansbury J, Strobl H, et al. Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification. Blood. 2011;117:3163–71.
- Wang J, Xu X. What is the optimal treatment for biphenotypic acute leukemia? Authors’ reply. Haematologica 2009;94:1780.
- Zheng C, Wu J, Liu X, Ding K, Cai X, Zhu W. What is the optimal treatment for biphenotypic acute leukemia? Haematologica. 2009;94:1778–80.
- Zhang C, Chen XH, Zhang X, Gao L, Gao L, Kong PY, et al. Stem cell collection in unmanipulated HLA-haploidentical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilized blood and bone marrow for patients with hematologic malignancies: the impact of donor characteristics and procedural settings. Transfus Med. 2010;20:169–77.
- Zhang C, Chen XH, Zhang X, Gao L, Gao L, Kong PY, et al. Mobilization of peripheral blood stem cells for autologous transplantation patients with hematologic malignancies: influence of disease, mobilization method, age and sex. Transfus Apher Sci. 2008;39:21–8.
- Chen X, Zhang C, Zhang X, Gao L, Gao L, Kong PY, et al. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies. Biol Blood Marrow Transplant. 2009;15:266–73.
- Downing JR, Shannon KM. Acute leukemia: a pediatric perspective. Cancer Cell. 2002;2:437–45.
- Wu SQ, Kuo J, Chen XR, Chen SA, Quinn JJ. Translocation (6;14) in childhood acute mixed lineage leukemia. Cancer Genet Cytogenet. 2003;141:178–9.
- Daser A, Rabbitts TH. The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis. Semin Cancer Biol. 2005;15:175–88.
- Aglietta M, De Vincentiis A, Lanata L, Lanza F, Lemoli RM, Menichella G, et al. Peripheral blood stem cells in acute myeloid leukemia: biology and clinical applications. Haematologica. 1996;81:77–92.
- Handretinger R, Lang P, Klingebiel T, Schumm M, Neu S, Geiselhart A, et al. Megadose transplantation of purified peripheral blood CD34+ progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant. 2001;27:777–831.
- Schattenberg AV, Dolstra H. Cellular adoptive immunotherapy after allogeneic stem cell transplantation. Curr Opin Oncol. 2005;17:617–21.
- Zhang C, Zhang X, Chen XH, Gao L, Gao L, Kong PY, et al. Factors influencing engraftment in HLA-haploidentical/mismatch related transplantation with combined granulocyte-colony stimulating factor-mobilized peripheral blood and bone marrow for patients with leukemia. Transfus Apher Sci. 2011;44:249–55.
- Huang XJ, Han W, Xu LP, Chen YH, Liu DH, Lu J, et al. A novel approach to human leukocyte antigen-mismatched transplantation in patients with malignant hematological disease. Chin Med J. 2004;117:1778–85.